US promotion practices probe piles on the woe for Questcor
This article was originally published in Scrip
Executive Summary
Questcor Pharmaceuticals' stock has taken a beating during the past week and lawyers who represent investors in shareholder lawsuits have taken notice as at least one group of plaintiffs' attorneys is looking into the company's disclosure on 24 September that the US government is investigating its promotional practices.